Prelude Therapeutics Inc (PRLD)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.30B
EV to revenue ratio (TTM)
7.40
EV to ebitda
-0.54
Financial Performance
Revenue (TTM)
$0.02B
Gross profit (TTM)
$0.02B
EBITDA
-$0.06B
Profitability
Operating margin (TTM)
-270.90%
Profit margin
-269.70%
Return on assets (TTM)
-27.20%
Return on equity (TTM)
-57.70%
Per Share Metrics
Revenue per share (TTM)
$0.27
EPS
-$0.73
Diluted EPS (TTM)
-$0.73
Book value
$1.30
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
13.38
Price to book ratio (TTM)
2.24
Growth
Quarterly earnings growth (YoY)
41.00%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
2
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.19